Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.
about
Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complexBinding to DPF-motif by the POB1 EH domain is responsible for POB1-Eps15 interactionBinding specificity and in vivo targets of the EH domain, a novel protein-protein interaction moduleMimotope vaccination--from allergy to cancerTowards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variantsCharacterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoiresUnusual binding properties of the SH3 domain of the yeast actin-binding protein Abp1: structural and functional analysisThe SH3 domains of endophilin and amphiphysin bind to the proline-rich region of synaptojanin 1 at distinct sites that display an unconventional binding specificityThe MEPS server for identifying protein conformational epitopesCan we infer peptide recognition specificity mediated by SH3 domains?Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains.'In vitro evolution' of ligands for HCV-specific serum antibodies.Identification of a LFA-1 region involved in the HIV-1-induced syncytia formation through phage-display technology.Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.Phage-displayed peptides that mimic aflatoxin B1 in serological reactivity.Peptide display libraries: design and construction.Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen.Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella.PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response.Characterization of murine coronavirus neutralization epitopes with phage-displayed peptidesIsolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitisDomain repertoires as a tool to derive protein recognition rules.Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity.The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.A family of concanavalin A-binding peptides from a hexapeptide epitope library.ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum.Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia.Phage display of random peptide libraries: applications, limits, and potential.Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model.Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica.Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines.Identification by phage display of the linear continuous MRPr1 epitope in the multidrug resistance-associated protein (MRP1).Characterization of a differential immunoscreen epitope of Plasmodium falciparum using combinatorial agents.Recognition specificity of individual EH domains of mammals and yeast.A mimotope defined by phage display inhibits IgE binding to the plant panallergen profilin.Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.Mimotopes of the Vi antigen of Salmonella enterica serovar typhi identified from phage display peptide library.Novel interaction partners of the CD2BP2-GYF domain.GYF domain proteomics reveals interaction sites in known and novel target proteins.Peptide display on filamentous phage capsids. A new powerful tool to study protein-ligand interaction.
P2860
Q22253918-F5950762-FC31-4C9B-B7DF-3CE79667D420Q24304396-BCE4964C-6786-4081-AEFF-4098F8788BCCQ24313034-94A3126D-4BBF-4003-996A-ECB676231EC9Q24608624-547A627D-D51B-4285-9ED0-A31C103D2DE0Q27470086-56FC828A-1391-499A-B073-40D1323446BDQ27480876-ECB67ACE-4151-4B01-B71A-B9B84EF26687Q27635472-82994FF1-9416-4FBA-BC7C-74BFBABC40A9Q28146109-78ECA0A0-82EC-441C-B801-B1837DD2CBF9Q29048145-C88F6D05-97C4-4D5A-8850-586DC161124FQ30165528-2C31FA57-6267-4145-931E-694B1316BB6EQ30175978-84642DD3-C93A-468D-BCCB-7F572C68531CQ30648972-BF312AF7-45D9-44F9-859A-7E4024747760Q30651744-8E60105A-3541-430D-9977-8D37EDD0DC4DQ30652825-89828A74-8CEA-402A-89C4-93D51AEABAE3Q30663958-3643CFB1-03E2-43C7-89BB-6F4E7635599CQ30796556-D55C642B-1058-4D18-A7F0-F948A4996F3CQ30817215-F1DDA0A9-255B-4241-A9B8-838FC51881CDQ30823928-479A829F-F36B-430F-A235-9152F318FF68Q30831917-E5E02EA2-BF49-4F8B-B628-EC7017B35F8FQ30871060-3EB0F555-A913-4DBC-97B3-D16E428703D3Q30895822-FF7B41C4-6389-4083-8A40-3E639D41B852Q30914825-D2EE6C6D-876C-4A09-8B62-C7F1E6A6B628Q30933370-33AFD9FB-3281-4CE9-A0CC-7883A63484DFQ30989402-B9C9CB95-BA78-45BD-A33D-ED323BBA1F8CQ30989706-CDDAF7DC-681E-4FE9-8133-1E6EAFA3EE8FQ31006433-22864643-C275-4311-A357-198A4F5A70DBQ31038915-F510DE8A-BB9F-4F6D-B069-6C152171E2EFQ31039269-441DD818-8D7D-43BC-9B23-67290E13709BQ31045955-F02562F8-FDEE-4354-B81D-908F4D376FF0Q31095304-3AD9DE81-C4A4-42C2-A8FC-20F00F24EAF6Q31114638-5830FC2F-80E8-4411-BEEF-976A01FB40ACQ31137284-EC4AC4A0-1F97-4E7C-8660-8684DA069B1EQ31780605-9C53F77C-F93E-4C81-8590-DB93F0EB3B1AQ31971634-6A099AF5-219B-4D57-BF7E-3FB629C1A760Q32013599-5852FA15-77A5-468A-B36D-82500485BE3EQ32053114-8103ADA5-A778-404A-B121-3429297ACED4Q33194824-A64131A6-EEDE-4B12-B5A0-3B4DA77BED47Q33218330-6CF3D083-3677-4AA9-B9B0-8E7EF78A8AD8Q33222213-93D9BB48-CF3A-4EA8-B50A-BA6E413D4410Q33230834-018C9FB3-7067-4D28-88DD-49DACCD529B8
P2860
Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Selection of antibody ligands ...... multivalent exposition vector.
@ast
Selection of antibody ligands ...... multivalent exposition vector.
@en
Selection of antibody ligands ...... multivalent exposition vector.
@nl
type
label
Selection of antibody ligands ...... multivalent exposition vector.
@ast
Selection of antibody ligands ...... multivalent exposition vector.
@en
Selection of antibody ligands ...... multivalent exposition vector.
@nl
prefLabel
Selection of antibody ligands ...... multivalent exposition vector.
@ast
Selection of antibody ligands ...... multivalent exposition vector.
@en
Selection of antibody ligands ...... multivalent exposition vector.
@nl
P50
P1476
Selection of antibody ligands ...... multivalent exposition vector
@en
P2093
G Cesareni
R Jappelli
P304
P356
10.1016/0022-2836(91)90213-P
P407
P577
1991-11-01T00:00:00Z